Visualization of Chronic Myocardial Infarction Using the Intravascular Contrast Agent MS-325 (Gadofosveset) in Patients

Aims. The aim of this study was to evaluate the potential of visualizing chronic myocardial infarction in patients using the intravascular CA MS-325 (gadofosveset, EPIX Pharmaceuticals, Mass, USA). Methods. Nine patients were enrolled in a clinical phase II multicenter trial for MRCA and perfusion i...

Descripción completa

Detalles Bibliográficos
Autores principales: Thouet, Thomas, Schnackenburg, Bernhard, Kokocinski, Thomas, Fleck, Eckart, Nagel, Eike, Kelle, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334354/
https://www.ncbi.nlm.nih.gov/pubmed/22536125
http://dx.doi.org/10.1100/2012/236401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334354/
https://www.ncbi.nlm.nih.gov/pubmed/22536125
http://dx.doi.org/10.1100/2012/236401

Ejemplares similares